Her primary areas of investigation include Biochemistry, Molecular biology, Stereochemistry, Mutant and Escherichia coli. Her study in Biochemistry focuses on Inclusion bodies, Protein folding, Native state, Plasma protein binding and Tryptophan. Her studies in Molecular biology integrate themes in fields like MHC class I, Leukocyte Immunoglobulin-like Receptor B1, Antigen, Immunoassay and HLA-G.
Her Stereochemistry research is multidisciplinary, incorporating elements of Residue, Site-directed mutagenesis, Conformational entropy, Protein structure and Methionine. As part of one scientific family, Izumi Kumagai deals mainly with the area of Mutant, narrowing it down to issues related to the Lysozyme, and often Monoclonal antibody, Antibody, Isothermal titration calorimetry, Enzyme and Molecule. Her Escherichia coli research integrates issues from Urea, Recombinant DNA, Guanidine, Green fluorescent protein and Chromatography.
The scientist’s investigation covers issues in Biochemistry, Antibody, Molecular biology, Antigen and Escherichia coli. Biochemistry and Stereochemistry are commonly linked in her work. Her Antibody research incorporates elements of Receptor, Epidermal growth factor receptor and Cancer immunotherapy.
Her research in Molecular biology intersects with topics in Cell culture, Expression vector, Complementary DNA, Fusion protein and Cytotoxicity. The Antigen study combines topics in areas such as Cytotoxic T cell, Cancer research and Monoclonal antibody. Her Lysozyme research is multidisciplinary, relying on both Isothermal titration calorimetry and Mutant, Site-directed mutagenesis.
Her primary scientific interests are in Antibody, Nanotechnology, Molecular biology, Biophysics and Epidermal growth factor receptor. Izumi Kumagai has included themes like Cancer cell, Cytotoxic T cell, Cancer research and Biochemistry in her Antibody study. Her work carried out in the field of Cancer research brings together such families of science as Epitope, Antigen, Receptor and T cell.
Izumi Kumagai has researched Biochemistry in several fields, including Cell culture and Imide. Her Molecular biology research includes elements of Growth factor receptor, Mutant, Expression vector and Function. Her Biophysics study combines topics in areas such as Proteases, Point mutation, Hinge, Biological activity and Surface plasmon resonance.
Antibody, Molecular biology, Cell culture, Epidermal growth factor receptor and Nanotechnology are her primary areas of study. Her study in Antibody is interdisciplinary in nature, drawing from both CD3 and Cytotoxicity. Her work deals with themes such as Cell cycle, Clone, Mutant and Expression vector, which intersect with Molecular biology.
Her Epidermal growth factor receptor study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fucose Depletion from Human IgG1 Oligosaccharide Enhances Binding Enthalpy and Association Rate Between IgG1 and FcγRIIIa
Akira Okazaki;Emi Shoji-Hosaka;Kazuyasu Nakamura;Masako Wakitani.
Journal of Molecular Biology (2004)
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G
Mitsunori Shiroishi;Kouhei Tsumoto;Kimie Amano;Yasuo Shirakihara.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Practical considerations in refolding proteins from inclusion bodies
Kouhei Tsumoto;Daisuke Ejima;Izumi Kumagai;Tsutomu Arakawa.
Protein Expression and Purification (2003)
Role of Arginine in Protein Refolding, Solubilization, and Purification
Kouhei Tsumoto;Mitsuo Umetsu;Izumi Kumagai;Daisuke Ejima.
Biotechnology Progress (2004)
Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)
Mitsunori Shiroishi;Kimiko Kuroki;Linda Rasubala;Kouhei Tsumoto.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent--application to a human single-chain Fv fragment.
Kouhei Tsumoto;Katsutoshi Shinoki;Hidemasa Kondo;Makoto Uchikawa.
Journal of Immunological Methods (1998)
Bioassisted Room‐Temperature Immobilization and Mineralization of Zinc Oxide—The Structural Ordering of ZnO Nanoparticles into a Flower‐Type Morphology
Mitsuo Umetsu;Masamichi Mizuta;Kouhei Tsumoto;Satoshi Ohara.
Advanced Materials (2005)
How additives influence the refolding of immunoglobulin-folded proteins in a stepwise dialysis system. Spectroscopic evidence for highly efficient refolding of a single-chain Fv fragment.
Mitsuo Umetsu;Kouhei Tsumoto;Masaki Hara;Kumar Ashish.
Journal of Biological Chemistry (2003)
Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
Satoru Misawa;Izumi Kumagai.
Efficient Leukocyte Ig-like Receptor Signaling and Crystal Structure of Disulfide-linked HLA-G Dimer
Mitsunori Shiroishi;Kimiko Kuroki;Toyoyuki Ose;Linda Rasubala.
Journal of Biological Chemistry (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: